Condition: Retinoblastoma · Sponsor: French Africa Pediatric Oncology Group
As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.
This description comes directly from the study's public registry record.
KARIM Mr ASSANI, Dr. · 00243971359726 · drassanik@gmail.com
BRENDA Ms MALLON, MSc · 0033142115411 · brenda.mallon@gustaveroussy.fr
Always discuss trial participation with your own doctor first.
| Hopital Yalgado Ouedraogo | Ouagadougou, Burkina Faso | Recruiting |
| CHU de Treichville à ABIDJAN | Abidjan, Côte d’Ivoire | Recruiting |
| CUK (Cliniques Universitaires de Kinshasa) | Kinshasa, Kinshasa City, Democratic Republic of the Congo | Recruiting |
| Cliniques Universitaires de Lubumbashi (CUL) | Lubumbashi, Democratic Republic of the Congo | Recruiting |
| HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona | Antananarivo, Ampefiloha, Madagascar | Recruiting |
| CHU Gabriel Touré (HGT) | Bamako, Mali | Recruiting |
| Hôpital Aristide Le Dantec, | Dakar, Senegal | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04425434